HDACi--targets beyond chromatin
- PMID: 19342155
- DOI: 10.1016/j.canlet.2009.02.028
HDACi--targets beyond chromatin
Abstract
Histone deacetylases (HDACs) play an important role in gene regulation. Inhibitors of HDACs (HDACi) are novel anti-cancer drugs, which induce histone (hyper-) acetylation and counteract aberrant gene repression. On the other hand, HDACi treatment can also result in decreased gene expression, and targeting HDACs affects more than chromatin. Recently, HDACi were shown to evoke non-histone protein acetylation, which can alter signaling networks relevant for tumorgenesis. Furthermore, HDACi can promote the degradation of (proto-) oncoproteins. Here, we summarize these findings and discuss how these substances could be beneficial for the treatment and prevention of human ailments, such as cancer and unbalanced immune functions.
Similar articles
-
Acetylation of non-histone proteins modulates cellular signalling at multiple levels.Int J Biochem Cell Biol. 2009 Jan;41(1):185-98. doi: 10.1016/j.biocel.2008.08.027. Epub 2008 Sep 2. Int J Biochem Cell Biol. 2009. PMID: 18804549 Review.
-
Targeting histone deacetylases for the treatment of cancer and inflammatory diseases.J Cell Physiol. 2006 Dec;209(3):611-6. doi: 10.1002/jcp.20781. J Cell Physiol. 2006. PMID: 17001696 Review.
-
Enhancing the apoptotic and therapeutic effects of HDAC inhibitors.Cancer Lett. 2009 Aug 8;280(2):125-33. doi: 10.1016/j.canlet.2009.02.042. Epub 2009 Apr 8. Cancer Lett. 2009. PMID: 19359091 Review.
-
Prospects: histone deacetylase inhibitors.J Cell Biochem. 2005 Oct 1;96(2):293-304. doi: 10.1002/jcb.20532. J Cell Biochem. 2005. PMID: 16088937 Review.
-
Acetylation of proteins as novel target for antitumor therapy: review article.Amino Acids. 2004 Jul;26(4):435-41. doi: 10.1007/s00726-004-0087-3. Epub 2004 Jun 11. Amino Acids. 2004. PMID: 15290351 Review.
Cited by
-
HDAC1 and HDAC2 integrate the expression of p53 mutants in pancreatic cancer.Oncogene. 2017 Mar 30;36(13):1804-1815. doi: 10.1038/onc.2016.344. Epub 2016 Oct 10. Oncogene. 2017. PMID: 27721407
-
Targeting histone deacetylases in pancreatic ductal adenocarcinoma.J Cell Mol Med. 2010 Jun;14(6A):1255-63. doi: 10.1111/j.1582-4934.2009.00974.x. Epub 2009 Nov 19. J Cell Mol Med. 2010. PMID: 19929947 Free PMC article. Review.
-
A novel mechanism involving coordinated regulation of nuclear levels and acetylation of NF-YA and Bcl6 activates RGS4 transcription.J Biol Chem. 2010 Sep 24;285(39):29760-9. doi: 10.1074/jbc.M110.121459. Epub 2010 Jul 14. J Biol Chem. 2010. PMID: 20630860 Free PMC article.
-
Targeting Histone Deacetylases in Idiopathic Pulmonary Fibrosis: A Future Therapeutic Option.Cells. 2022 May 12;11(10):1626. doi: 10.3390/cells11101626. Cells. 2022. PMID: 35626663 Free PMC article. Review.
-
Histone 3.3 participates in a self-sustaining cascade of apoptosis that contributes to the progression of chronic obstructive pulmonary disease.Am J Respir Crit Care Med. 2013 Sep 15;188(6):673-83. doi: 10.1164/rccm.201302-0342OC. Am J Respir Crit Care Med. 2013. PMID: 23924319 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources